James T. McCracken, MD

University of California, Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior, Los Angeles, California

JCP
Pharmacotherapy After CBT in Anxious Youth
Original Research

December 5, 2022

This study of youth with anxiety disorders compared cognitive-behavioral therapy (CBT) non-remitters who initiated pharmacotherapy to those who did not and sought to identify predictors of the decision to...
Jeffrey R. Strawn, Jeffrey A. Mills, Richard Rothenberg, et al
JCP
Correction

October 23, 2019

Benedetto Vitiello, Graham Emslie, Gregory Clarke, et al
JCP
Meta-Analysis

February 22, 2017

While exposure-based cognitive-behavioral therapy is effective for anxiety disorders, many patients often experience inadequate results from this treatment. This meta-analysis examines whether d-Cycloserine as an adjunct to CBT might...
Joseph F. McGuire, Monica S. Wu, John Piacentini, et al
d-Cycloserine in Exposure Therapy ">
JCP
Original Research

August 4, 2015

Chadi A. Calarge, Ekhard E. Ziegler, Nicole Del Castillo, et al
JCP
Article

November 16, 2010

Benedetto Vitiello, Graham Emslie, Gregory Clarke, et al
JCP
Article

December 15, 2005

James T. McCracken
JCP
Article

June 1, 2002

James T. McCracken, John T. Walkup, Harold S. Koplewicz

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe